As hospital imaging departments look to replace aging nuclear scanners with updated technology, many are asking if cardiac positron emission tomography (PET) might be a better option over the traditional single photon emission computed tomography (SPECT) systems. There are several factors to consider when evaluating PET versus SPECT, including costs, speed, exercise versus pharmacological stress, access to radiotracers and what addition information PET can offer for a more precise diagnosis.
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced the ...
Andrew Weintraub, M.D., FACC, associate director, of the Interventional Cardiology and Vascular Center, medical director ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Carey Kimmelstiel, M.D., FACP, FACC, director, interventional cardiology, director, cardiac catheterization lab, Tufts ...
Transradial access for percutaneous coronary intervention (PCI) in the United States has grown rapidly over the past 20 ...
The Centers for Disease Control and Prevention (CDC) highlights physical activity as one of four key behaviors people ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
February 14, 2020 – The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) ...
February 13, 2020 — The U.S. Food and Drug Administration (FDA) has issued its final guidance on "Peripheral Vascular ...
This video illustrates how the Micra AV leadless pacemaker is delivered via catheter and enables atrioventricular (AV) ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
February 13, 2020 — The U.S. Food and Drug Administration (FDA) has approval of Micra AV, the world’s smallest pacemaker ...
February 13, 2020 — The U.S. Food and Drug Administration (FDA) cleared software to assist medical professionals in the ...
February 12. 2020 — Philips announced a new randomized controlled trial to assess patient outcomes after receiving a ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
February 12, 2020 — The U.S. Food and Drug Administration (FDA) has approved Carmat's investigational device exemption ...
February 12, 2020 — The University of Wisconsin (UW) Health’s University Hospital in Madison, Wis., recently became the ...
Cardiovascular diseases (CVDs) are among the leading causes of death across the globe. For patients suffering from high ...